Grant Proposals

  1. Dr Lori Jordan (11/14) Ischemic Brian Injury and Cognitive Impairment in Adolescents and Young Adults with Congenital Heart Disease
  2. Dr Kanika Bagai (11/14) Assessing effects of treatment for OSA diagnosed under alternative criteria
  3. Dr Beth Malow (11/14) Optimizing health and well-being in adolescents and adults with autism spectrum disorders
  4. Dr Jun Li (10/14) Pathophysiology of Conduction Block in HNPP
  5. Dr Olivia Veatch and Dr Beth Malow (9/14) Melatonin Pathway Genes Contributing to Insomnia in Autism Spectrum Disorder
  6. Dr Beth Malow (7/14) Parent sleep education in community settings
  7. Dr David Charles (8/14) Phase 3 trial in DBS
  8. Dr Jun Li (7/14) Genetic Modifier of CMT
  9. Dr Kanika Bagai (2/13, 7/13, 5/14) Obstructive Sleep Apnea and Assessment of Risk Factors associated with Biological Stress in Transient Ischemic Attacks and Minor Stroke: Influence on Oxidative Stress, Inflammation and Fibrinolytic Activity
  10. Dr Aaron Bowman (4/14) Mechanisms of Manganese Neurotoxicity
  11. Dr Beth Malow (4/14) PCORI Sleep education study proposal
  12. Dr David Chareles (4/14) BioVU proposal on PD
  13. Dr David Charles (3/14) Prevalence & neuropsychological assessment in PD patients with BDNF mutations
  14. Dr Olivia Veatch (2/14) Power analysis for Autism Speaks grant
  15. Dr David Charles (1/14) Proposal to FDA on DBS in early PD patients
  16. Dr Amanda Peltier (9/13, 10/13) Diabetic peripheral neuropathy K02 proposal
  17. Dr Subramaniam Sriram (7/13) Statistical analysis planning and power analysis for Multiple sclerosis
  18. Dr Lori Jordan (6/13) Clinical and Imaging Determinants Associated with Outcome after Arterial Ischemic Strokes in Children
  19. Dr Beth Malow (5/13) Association between sleep bruxism (teeth grinding) and sleep talking with repetitive behaviors and sensory processing
  20. Dr Beth Malow (2/13) Sleep in Autism: Associations with Repetitive Behavior
  21. Dr Beth Malow (2/13) Crossover study for Autism Speaks proposal
  22. Dr Lori Jordan (2/13) Acute arterial ischemic strokes study for Doris Duke grant
  23. Dr Siddharama Pawate (1/13) K23 proposal, MS study
  24. Dr David Charles (11/12) Hub and spoke study
  25. Dr Jun Li (10/12) Novel mechanism of conduction block
  26. Dr Lori Jordan (10/12) Clinical and Imaging Determinants Associated with Outcome after Arterial Ischemic Strokes in Children
  27. Dr Michelle Kvalsund (9/12) Distal symmetric polyneuropathies (DSPN) are common in HIV infection
  28. Dr William Burnette (9/12,10/12) Sleep and cognition in DMD
  29. Dr Art Walters (8/12) Inflammatory and Immunological markers in Restless Legs Syndrome
  30. Dr Lori Jordan (6/12, 10/12) Ischemic Brain Injury and Cognitive Impairment in Adolescents and Young Adults with Congenital Heart Disease
  31. Dr Amanda Peltier (3/12, 12/12) Evaluation of dermal myelinated fibers in diabetes mellitus - resubmission
  32. Dr Peter Donofrio (2/12) The use of actigraphy to assess movement in ALS patients
  33. Dr BethAnn McLaughlin (2/12) Vanderbilt Neurology Telemedicine Initiative
  34. Dr Bryan Burnette (1/12) SLEEP-DISORDERED BREATHING IN AMBULATORY BOYS WITH DUCHENNE MUSCULAR DYSTROPHY
  35. Dr Sriram (2/12) Defective cell cycle checkpoints and DNA damage responses in multiple sclerosis
  36. Dr BethAnn McLaughlin (2/12) Vanderbilt Neurology Telemedicine Initiative
  37. Dr Dan Claassen (1/12) A VICTR proposal.
  38. Dr Sid Pawate (10/11) Spinal cord involvement in multiple sclerosis: a magnetic resonance imaging study
  39. Dr David Charles (7/11) Long-Term Follow-Up of OnabotulinumtoxinA (Botoxģ) Injection and Intrathecal Baclofen Therapy for the Treatment of Spasticity in Patients with Intellectual Disabilities
  40. Dr Amanda Peltier (7/11) Evaluation of dermal myelinated fibers in diabetes mellitus
  41. Dr Li (5/11) FIG4 gene and sensory polyneuropathy.
  42. Dr Li (4/11) The Biological Function of SVIP
  43. Dr Li (4/11) Identification of SEPT9 Gene Mutations in Patients with Hereditary Neuralgic Amyotrophy.
  44. Dr Art Walters (4/11) Magnetic Resonance Imaging of Patients with Restless Legs Syndrome Verses Controls: The Search for Silent Stroke
  45. Dr Kanika Bagai (4/11) Obstructive Sleep Apnea in Women: Influence on Biomarkers of Oxidative Stress, Inflammation and Fibrinolytic Activity
  46. Dr Amanda Peltier (2/11 - 3/11, 5/11-6/11) Demylination features in diabetic polyneuropathy
  47. Dr Elias Abou-zeid (2/11) Does Mitofusin-1 modify the phenotypic expression of CMT2A?
  48. Dr Jingqiong Kang (1/11) A potential mechanism based treatment for epilepsy syndromes
  49. Dr Kanika Bagai (12/10) Variability of Fibrinolytic Markers and Endothelial Function in Obstructive Sleep Apnea
  50. Dr Art Walters (12/10) Magnetic resonance imaging study of patients with restless legs syndrome vs. controls: the search for silent strokes
  51. Dr Brandon Ally (11/10) Cognitive and Neural Correlates of the Picture Superiority Effect in Alzheimer's Disease
  52. Dr Hasan Sonmezturk A Statistical Analysis and Comparison of Anti-epileptic Selection Among Physicians from Different Specialties.
  53. Dr David Charles (10/10) Prevalence of spasticity and clinical impact in nursing home residents (resubmission)
  54. Dr Scott Boyd (9/10) A Study to Validate the use of Functionally Effective AHI as a Measurement of CPAP Adherence and Effectiveness
  55. Dr Luke Tomycz (9/10) Stent-Assist Versus Balloon Remodeling in the Embolization of Carotid Sidewall, Wide-Neck Intracranial Aneurysms: A Multi-Center Randomized-Control Trial
  56. Dr Amanda Peltier (9/10) Evaluation of Dermal Myelinated Fibers in Patients with Diabetic Polyneuropathy
  57. Dr Kang Jingqiong (8/10) Effect of 4-PBA on the surface and total expression of both the wild type and mutant GABAA receptors in HEK 293T cells with flow cytometry
  58. Dr Amanda Peltier (7/10) Abnormal QSART in HIV-infected patients with an autonomic dysfunction or distal sensory neuropathy
  59. Dr Art Walters (7/10) MRI study of Restless Legs Syndrome patients versus controls: The search for silent strokes
  60. Dr Jun Li (6/10) Molecular Signature of Dermal Nerves in CMT1A
  61. Dr David Charles (5/10) Long-term follow up of deep brain stimulation for early stage Parkinson's disease
  62. Dr Art Walters (5/10) Study of cerebrospinal fluid endogenous opioids in patients with Restless Legs Syndrome versus controls.
  63. Drs Peter Conrad and Laura Diedrich (4/10) Optimal Catheter location for Intrathecal Baclofen Therapy in Spasticity.
  64. Dr Scott Boyd (4/10) Comparative Long Term Effectiveness of Maxillomandibular Advancement and CPAP for the Treatment of Obstructive Sleep Apnea.
  65. Dr Art Walters (3/10) Circadian Rhythm of the Restless Legs Syndrome
  66. Dr Lana Jeradeh Boursoulian (2/10) Sleep organization before and after selective amygdalohippocampectomy in patients with mesial temporal lobe epilepsy.
  67. Dr Peltier (8/09) Palliative care education grant.
  68. Drs Boyd, Walters, Malow (8/09) Surgical Treatment of Obstructive Sleep Apnea by Maxillomandibular Advancement
  69. Dr David Charles (7/09) Emotion recognition deficits in early stage Parkinson's Disease
  70. Dr Art Walters (7/09) Study of Cerebrospinal Fluid Endogenous Opioids and Blood mRNA in Patients with Restless Legs Syndrome Versus Controls.
  71. Dr David Charles (7/09) Progression of early Parkinson's disease after treatment with DBS, an extension of an ongoing pilot trial
  72. Dr Ram Siriram (7/09) Regulation of p53 and p53 isoforms by beta interferon
  73. Dr Art Walters (6/09) Circadian Rhythm of the Restless Legs Syndrome.
  74. Dr David Charles (6/09) Spasticity prevalence and clinical impact in long term care residents, resubmission.
  75. Dr David Charles (6/09) Inter-rater reliability of a spasticity diagnosis algorithm.
  76. Dr Sriram (5/09) DNA damage pathway defects in MS.
  77. Dr Art Walters (5/09) Magnetic Resonance Imaging study of patients with Restless Legs Syndrome versus controls: The search for silent strokes.
  78. Dr Art Walters (2/09) Study of cerebrospinal fluid endogenous opioids in patients with Restless Legs Syndrome versus controls.
  79. Dr David Charles (2/09) Spasticity prevalence and clinical impact in long term care residents.
  80. Dr Scott Boyd (2/09) Surgical Treatment of OSA by Maxillomandibular Advancement.
  81. Dr Chris Lee and Amanda Peltier (2/09) A study to look at repeated ultrasound measurements of muscle thickness over time.
  82. Dr Arthur Walters (2/09) Study of cerebrospinal fluid endogenous opioids in patients with Restless Legs Syndrome versus controls
  83. Dr Fenna Phibbs (1/09) GaitRite analysis of walking.
  84. Dr Eliza Robertson and Peter Donofrio (1/09) Double crush syndrome study.
  85. Dr Kanika Bagai (12/08) Variability of Fibrinolytic Markers and Endothelial Function in obese and non-obese patients with Obstructive Sleep Apnea.
  86. Dr Amanda Peltier (9/08) Sleep-Disordered Breathing in Amyotrophic Lateral Sclerosis.
  87. Dr David Charles (6/08 - 8/08) Deep brain stimulation for progression of Parkinsonís disease.
  88. Dr Gregory Barnes (6/08) Relation of Sleep Epileptiform Activity to Insomnia and Daytime Behaviors in Children with Autism Spectrum Disorders.
  89. Dr. David Charles (2/08) Retrospective analysis of PD progression after DBS using levodopa total daily dose as a surrogate disease marker.
  90. Dr. David Charles (11/07) Retrospective Analysis of Cervical Dystonia Patient Population and Treatment Experience at Vanderbilt University.
  91. Dr David Charles (9/07) Prevalence and treatment of spasticity in veterans with brain injuries living in long term care facilities.
  92. Dr Siddharama Pawate (9/07)Detection of brain iron in multiple sclerosis.
  93. Dr David Charles (8/07 ) DBS study. Data and safety monitoring reports.
  94. Dr Amanda Peltier (6/07) Qualitative Approach to Skin Biopsy in Diabetic Neuropathy Using Immunolabeling for Nociceptive C Fiber Subclasses. Clustering analysis, GEE.
  95. Dr Kanika Bagai (06/07) Variability of Fibrinolytic markers and Endothelial Function in Obstructive Sleep Apnea. Statistical analysis of circadian variations using mixed effects models. (Report)
  96. Dr Pradumna Singh (03/07)Is There a Role for I.V. Levetiracetam in Controlling Acute Repetitive Seizures in the Epilepsy Monitoring Unit?
  97. Dr David Charles (3/07) Botox for cervical pain study. Cross-over study.
  98. Dr Sriram Subramaniam (2/07) A grant looking at correlations between immunochemistry values and MRI measures for mice.
  99. Dr Amanda C. Peltier (2/07)Differences in Sympathetic Function Between African Americans and Caucasians.
  100. Dr Kimberly Hutchison (2/07) Neural correlates of adaptation to sleep deprivation in obstructive sleep apnea - A Pilot Study. Database setup.
  101. Dr Kanika Bagai (2/07 - 7/07)Variability of Fibrinolytic markers and Endothelial Function in Obstructive Sleep Apnea. Statistical modelling of circadian variation of biomarkers.
  102. Dr Fenna Phibbs (2/07)A cross-over study looking at monopolar vs. biopolar stimulation on patients quality of life.
  103. Dr Peter D. Donofrio (2/07)Theophylline and Respiratory Fatigue in Amyotrophic Lateral Sclerosis. A two-period crossover study.
  104. Dr Kanika Bagai (10/06) Obstructive Sleep Apnea Syndrome and PAI-1.
  105. Dr. Amanda C. Peltier (9/06)A grant to look at the specific percentages of nociceptive C fiber subclasses affected in different neuropathies to determine if this information could be used for diagnostic purposes.
  106. Dr Mike Edgeworth (7/06) A PHASE I/II STUDY OF COMBINING SUNITINIB WITH TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME. Design of a cancer clinical trial.
  107. Dr David Charles (5/06) Treatment for spasticity in Tenn.
  108. Dr Michael K. Cooper (4/06) Association of Hedgehog pathway activity with brain tumors.
  109. Dr Moneeb Ehtesham (3/06) Assistance with grant preparation. Wilcoxon test.
  110. Drs Nabil J. Azar, Bassel Abou-Khalil (1/06 - 2/06)Seizure Interval Prolongation (SIP) effect after brief AED withdrawal.
  111. Drs David Charles, Chris Kao (1/06 - 2/06)Electrical activity within STN and disease progression in PD.
  112. Dr David Charles (1/06 ) Safety and Tolerability of Neurostimulation in Early State Parkinsonís Disease.
  113. Drs Bassel Abou-Khalil, Pradumna Singh, Amir Arain (12/05)Effect of Educational and Social Services on Seizure Control and Quality of Life Outcome in Patients Presenting to the Emergency Room with Seizures. Design of quality of life studies in clinical trials.
  114. Drs Gregory Barnes and Anup Patel (11/05) Levetiracetam induced suppression of Refractory Neonatal Seizures. Measuring change from baseline.

Manuscripts

  1. Dr Jun Li (12/14) Pathophysiology of Conduction Block in HNPP
  2. Dr David Charles (11/14 - ) Tremor in DBS patients
  3. Dr David Charles (11/14) Neuropsychological Effects of Deep Brain Stimulation in Subjects with Early Stage Parkinsonís Disease in a Randomized Clinical Trial, reanalysis with different cohorts, revision
  4. Dr Jun Li (10/14) Reactivation of Lysosomal Ca2+ Efflux Rescues Abnormal Lysosomal Storage in FIG4 Deficient Cells
  5. Dr David Charles (8/14 -) A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Bilateral-Subthalamic Nucleus Deep Brain Stimulation in Subjects with Early Stage Parkinson's Disease, analysis with different cohorts
  6. Dr Art Walters (7/14, 8/14, 9/14) Distribution and depth of RLS symptoms
  7. Dr Amanda Peltier (8/14) Sweat volume in African Americans and Caucasians
  8. Dr Amanda Peltier (8/14) Diabetic neuropathy study
  9. Dr David Charles (7/13 - 11/14) Brain Derived Neurotrophic Factor rs6265 Polymorphism Impacts Response to Antiparkinsonian Therapies
  10. Dr Beth Malow (7/14-11/14) Sleep in Children with Autism Spectrum Disorders: How are Measures of Parent report and Actigraphy Related and Affected by Treatment Interventions?
  11. Dr Andrť Diedrich , Dr Beth Malow (7/14 - ) Heart Rate Variability During Sleep in Children with Autism Spectrum Disorders
  12. Dr David Chareles (2/14) Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinsonís Disease
  13. Dr Kanika Bagai (2/14) Circadian Variability of Fibrinolytic Markers and Endothelial Function in Patients with Obstructive Sleep Apnea
  14. Dr Beth Malow (1/14) Melatonin in Children with Autism Spectrum Disorders: Endogenous and Pharmacokinetic Profiles in Relation to Sleep
  15. Dr Suzanne Goldman (8/13) Characterization of the Sleep Phenotype in Adolescents and Young Adults With Autism Spectrum Disorders
  16. Dr David Charles (3/13) Neuropsychological Effects of Deep Brain Stimulation in Early Stage Parkinsonís Disease
  17. Dr Scott Kutscher (7/12, 8/12) Longitudinal study of baseball players performance
  18. Dr Amanda Peltier (7/12) Evaluation of Dermal Myelinated Fibers in Diabetes Mellitus
  19. Dr David Charles (8/12,10/12) Early State Parkinsonís Disease-Autonomics
  20. Dr David Charles (6/12,7/12, 8/12,9/12,10/12,11/12) Safety and Tolerability of Neurostimulation in Early State Parkinsonís Disease
  21. Dr Nabil Azar (6/12) Yield of long-term monitoring for epilepsy
  22. Dr Nabil Azar (6/12, 7/12, 8/12,11/12) Temporal Pettern of Drug Withdrawal Seizures in EMU
  23. Dr David Charles (5/12) Analysis of Neuropsychiatric data from the DBS clinical trial
  24. Drs Francine Arneson and Amanda Peltier (4/12) Attitudes towards Palliative and End-of-life Care in ALS Patients and Providers
  25. Dr Kanika Bagai (3/12) Influce of obstructive sleep apnea in women on biomarkers of oxidative stress and inflammation and fibrinolytic activity
  26. Dr David Charles (5/11) A Prospective Randomized, Single Blind Pilot Clinical Trial to Assess Preliminary Safety and Tolerability of Deep Brain Stimulation in Early Stage Parkinsonís Disease: Rationale, Recruitment, Retention and Design
  27. Dr Amanda Peltier (3/11) Effect of Mild Hyperglycemia on Autonomic and Peripheral Nerve Function in Obstructive Sleep Apnea
  28. Dr Elias Abou-zeid (10/10 - ) Reliability of the Quantitative Sudomotor Axon Reflex Test is dependent of skin temperature
  29. Dr Francine Arneson (10/10 - ) Attitudes towards Palliative and End-of-life Care in ALS Patients and Providers
  30. Dr David Charles (8/10 -) Changes in Autonomic Function in Patients with Early Stage Parkinsonís Disease (Report)
  31. Dr David Charles (7/10) Deep Brain Stimulation of Bilateral Subthalamic Nuclei in Early Stage Parkinsonís Disease: Experience of a Novel Pilot Clinical Trial
  32. Dr Nabil Azar (5/10 -) Non-diagnostic initial long-term video-EEG study, and yield of repeat studies
  33. Dr Art Walters (4/10 -) L-Dopa improves RLS in a double-blind trial in children
  34. Dr Lisa Hermann (4/10 - ) THE USE OF EXTRAVENTRICULAR DRAINS IN INTRACEREBRAL HEMORRHAGE
  35. Dr Art Walters (2/10) Prevalence of stroke in Restless Legs Syndrome: Initial results point to the need for more sophisticated studies.
  36. Dr Scott Boyd (2/10 -) Surgical Treatment of OSA by Maxillomandibular Advancement. (Report)
  37. Dr Kanika Bagai (11/09 - ) Circadian variability of Fibrinolytic Markers and Endothelial Dysfunction in patients with Obstructive Sleep Apnea. (Report)
  38. Dr Amanda Peltier (11/09 - ) AUTONOMIC DYSFUNCTION IN OBSTRUCTIVE SLEEP APNEA - ROLE OF IMPAIRED GLUCOSE REGULATION. (Report)
  39. Dr David Charles (9/09-) Retrospective analysis of PD progression after DBS using levodopa total daily dose as a surrogate disease marker (Report)
  40. Dr Kim Hutchison (9/09-) Neural correlates of adaptation to sleep deprivation in obstructive sleep apnea - A Pilot Study (Report)
  41. Dr Fanglin Zhang and Subramaniam Sriram (6/09-8/10) Role of HDAC3 on p53 expression and apoptosis in T lymphocytes of patients with multiple sclerosis
  42. Drs Nabil J. Azar, Bassel Abou-Khalil (6/09-11/10) Discriminating Features of Convulsive Epileptic and Non-epileptic Seizures.
  43. Dr Amanda Peltier (2/09 - ) QUANTITATIVE SUDOMOTOR AXON REFLEX TEST AND UTAH EARLY NEUROPATHY SCALE IN HIV INFECTION. (Report)
  44. Dr Salman Zubair (9/08-) UTILITY OF 2HR VIDEOEEG MONITORING COMPARED TO ROUTINE EEG.
  45. Dr Siddharama Pawate (9/08 -12/08, 11/09-3/11) Deep gray matter T2 hypointensity in multiple sclerosis and other neurological diseases: a 3T MRI study. (Report)
  46. Drs Nabil J. Azar, Bassel Abou-Khalil (2/08 - )Seizure Interval Prolongation (SIP) effect after brief AED withdrawal. (Report)
  47. Dr Amanda Peltier (8/07 - 11/07, 1/09)Distal Sudomotor Abnormalities in Postural Tachycardla Syndrome. (Report)
  48. Dr Davit Mrelashvili (6/07 - 3/08)Pregabalin Efficacy and Tolerability in Patients with Intractable Partial Seizures A Post-Marketing Analysis.
  49. Dr Siddharama Pawate (8/07 - 10/07)Mycophenolate moefetil in Multiple Sclerosis.
  50. Dr Nabil Azar (8/07)Oxcarbazepine withdrawal seizures during epilepsy monitoring. Poisson regression with repeated measures, survival analysis.
  51. Dr Mengesha, Dr Abou-Khalil (08/07)Visual Field Defects after Selective Amygdalohippocampectomy and Standard Temporal Lobectomy. Generalized estimating equations for repeated measures.
  52. Dr Kanika Bagai (03/07 - 11/07, 1/09)The Neglected Spectrum of REM Obstructive Sleep Apnea.
  53. Dr Kanika Bagai (10/06 - 7/07) Electrophysiological Patterns of Diabetic Polyneuropathy. Poisson model with repeated measures.
  54. Dr Amanda Peltier (10/06 - 11/07)Reliability and Sensitivity of Electrophysiology Studies in a Clinical Trial of Early Neuropathy Associated with Impaired Glucose Regulation. Intraclass correlations.
  55. Drs Nabil Azar, Aubrey Wright, Bassel Abou-Khalil (10/06 - 2/07)Generalized Tonic-Clonic Seizures after Acute Oxcarbazepine Withdrawal.
  56. Drs Nabil Azar, Tania F Tayah and others (10/06 -1/07 )Value of post-ictal breathing pattern in differentiation of generalized tonic-clonic seizures, non-epileptic convulsive seizures and hypermotor frontal seizures. Logistic prediction model.
  57. Dr Kimberly Hutchison (7/06 - 5/07 ) First night effect in hospital and hotel-based laboratory.
  58. Dr Sriram Subramaniam (2/06 - )Gene expression profiling for multiple sclerosis. Analysis of microarray data with Bioconductor software.
  59. Dr Amanda C. Peltier (1/06 - 3/06)Autonomic Dysfunction in Obstructive Sleep Apnea Is Associated with Impaired Glucose. Analysis of results.

Consultations, Short Data Analysis, Abstracts for Meetings

  1. Dr Amanda Peltier (10/14) Dermal Nodes in Diabetes Mellitus
  2. Dr Derek Huang (9/14) Pain study for CMT patients
  3. Dr Katty Kang (9/14) Statistics for analyzing normalized protein expressions.
  4. Dr David Charles (8/14) BDNF mutations in PD patients
  5. Dr Aurea Pimenta (8/13,10/13, 7/14) Consultation on RNA-seq analysis
  6. Dr Katty Kang (5/14) Discussion on statistical checklist
  7. Dr Art Walters (4/14) Opioids for Restless Legs Syndrome
  8. Dr Jun Li (4/14) Discussion on reliability statistics for manuscript revision.
  9. Dr Siddharama Pawate (10/13, 2/14) The Study of natalizumab dose interval
  10. Dr Fanglin Zhang (3/14) GEO dataset help
  11. Dr Art Walters (1/14) Statistics for repeated measures
  12. Dr Kevin Haas (12/13, 6/14) Non convulsive status epilepticus in Neuro ICU
  13. Dr Beth Malow (10/13) Sleep education proposal, power analysis
  14. Dr Brandon Ally (9/13) Consultation on experimental design for grant proposal
  15. Dr Kanika Bagai (8/13) Stroke and fibriolytic markers
  16. Dr Daniel Claassen (8/13) Determine clusters, or groups with which to categorize
  17. Dr Harold Moses (8/13, 9/13) Marijuana use in MS patients
  18. Dr Amanda Peltier (8/13) Abnormalities in the Node of Ranvier in Type 1 Diabetes Observational cross-sectional study
  19. Dr Amir Arain (6/13, 11/13) Epilepsy in the Elderly Study
  20. Dr Beth Malow (7/13) Autonomic Measures During Sleep in Children with Autism Spectrum Disorders
  21. Dr Jun Li Lab members (6/13) Power Analysis and Sample Size tutorial
  22. Dr Michelle Kvalsund (5/13) Consultation on experimental design for proposal
  23. Dr Lakisha Jordan (3/13) Quality of Life in Children after Intracerebral Hemmorage
  24. Dr Kanika Bagai (3/13) Influence of Obstructive Sleep Apnea in Women on Biomarkers of Oxidative Stree, Inflammation and Fibrinolytic Activity
  25. Dr Lori Jordan (3/13) Quality of life after intracerebral hemorrhage
  26. Dr Hamilton Peters (2/13, 3/13) Selection of AEDs among Neurologist and Non-neurologist
  27. Dr Amir Arain (2/13) Psuedoseizure communication study
  28. Dr Hanson Sonmezturk (1/13) PNES + ES and NES comparison study
  29. Dr Lakisha Jordan (1/13) Stroke Patients Care Survey
  30. Dr Chris Lee (11/12) Frequency of Accelerated Loss of Ventilatory Function
  31. Dr Hasan Sonmezturk (10/12) EEG monitoring study in ICU patients
  32. Dr Jun Li (8/12) Rater's Reliability
  33. Dr Jordan Lakisha (7/12, 8/12) Stroke Patients Care Survey
  34. Dr Jordan Lakisha (7/12, 8/12, 11/12) Non-convulsive Seizures in Neuro-ICU
  35. Dr Amanda Peltier (6/12, 7/12,10/12, 3/13) Demylination Features in Diabetic Polyneuropathy
  36. Dr Ikuko Laccheo (6/12, 10/12) Non-convulsive Seizures in Neuro-ICU
  37. Drs Amar Bhatt & Nabil Azar (6/12) Yield of Long-Term Monitoring for Epilepsy Based on Age Group
  38. Xuan Huang and Dr Robert L. Macdonald (5/12) the mRNA level of Q40X mutant subunits are increased by blocking NMD
  39. Dr David Charles (5/12) Blinding analysis for the DBS trial.
  40. Drs Francine Arneson and Howard S. Kirshner (5/12) Stroke Patients Care Survey
  41. Dr Ikuko Laccheo (5/12) Non-convulsive Seizures in Neuro-ICU
  42. Dr David Charles (4/12) Effect of Deep Brain Stimulation on Autonomic Function in Early Parkinson's Disease
  43. Xuan Huang and Dr Robert Macdonald (4/12) Consultation on power analysis for a manuscript
  44. Drs Jill Olson and Amanda Peltier (3/12) Statistics for a neuromuscular survey
  45. Dr Fenna Phibbs (3/12) Hospital stay after DBS
  46. Dr David Charles (3/12) Effect of Dopamine Agonist Medication on Blood Pressure in Early Parkinson's Disease
  47. Dr David Charles (3/12) Safety and tolerability of neurostimulation in early stage Parkinson's disease
  48. Dr Amir Arain (3/12) Two hour EEG study
  49. Dr Bruce Carter and Bradley Kraemer (2/12) Analysis of a small experiment
  50. Dr Lakisha Jordan (2/12) Predictors of recovery from intracerebral hemorrhage in children
  51. Dr Aurea Pimenta (2/12) Consultation on sample size calcualtions
  52. Dr Art Walters (2/12) Consultation on mixed models and microarray study
  53. Drs Mengnan Tian and Robert Macdonald (2/12) The Intronic GABRG2 Mutation Associated with CAE Altered Subunit mRNA Intron Splicing, Produced a Truncated Subunit and Activated Nonsense-Mediated Decay
  54. Dr Martin Gallagher (1/12) consultation on a statistical test
  55. Dr Nabil Azar (1/12) Temporal pattern of drug withdrawal seizures in EMU
  56. Dr Andre Lagrange (1/12) Hepatically Metabolized Seizure Medications and Bone Imaging
  57. Dr Amir Arain (11/11) Hypermotor seizure study
  58. Dr Ikuko Laccheo (9/11) Non-convulsive seizures in neuro-ICU
  59. Dr Jun Li (9/11) Rater's reliability
  60. Dr Hamilton Peters (9/11) Selection of AEDs among neurologists and non-neurologists
  61. Dr Nabil Azar (6/11) Lamotrigine, levetiracetam, oxcarbazepine, and phenytoin withdrawal seizures in the epilepsy monitoring unit: severity and temporal pattern
  62. Dr Nabil Azar (6/11) How do neurologists and non-neurologists choose an antiepileptic drug?
  63. Dr Jun Li (6/11) Association between Inter-nodal length and axon diameter, a random coefficient model
  64. Dr Jun Li (6/11) Nerve conduction study. report
  65. Dr David Charles and Anna Molinari (6/11) Changes in Autonomic Function in Patients with Early Stage Parkinsonís Disease
  66. Kate Gurba and Dr Bob Macdonald (5/11) Analysis of protein expressions for a time course experiment
  67. Dr Martin Gallagher (5/11) Statistical test for body mass over time
  68. Dr Beth Malow (12/10) Supplemental Melatonin Decreases Time to Fall Asleep IN Children with AUTISM
  69. Dr Art Walters (11/10) The association between RLS and IBS
  70. Dr Jun Li (10/10) Distinct Pathogenic Processes between Fig4-Deficient Motor and Sensory Neurons
  71. Dr Nakul Shekhawat (10/10) A cross-section of neurovascular centers of excellence from around the country.
  72. Dr Amanda Peltier (6/10) Hyperglycemia in Obstructive Sleep Apnea is Associated with Decreased Sympathetic Activity.
  73. Dr Li (8/10) Some analysis of neuronal data. report
  74. Dr Azar (6/10) Drug withdrawal study.
  75. Dr Suzanne Goldman (6/10) Parental and Child sleep patterns measured by actigraphy. report
  76. Dr David Charles (12/09) Retrospective analysis of PD progression after DBS using levodopa total daily dose as a surrogate disease marker, analysis on projected cost estimate. (abstract submitted 12/18/09)
  77. Dr Art Walters (12/09) Prevalence of Irritable Bowel Syndrome (IBS) in Restless Legs Syndrome (RLS) population (abstract submitted 12/15/09)
  78. Dr Suzzane Goldman (12/09) Parental stress is associated with insommia in children. (abstract submitted 12/15/09)
  79. Dr Kim Hutchinson (12/09) Neural correlates of adaptation to sleep deprivation in obstructive sleep apnea - A Pilot Study (abstract submitted 12/15/09)
  80. Drs Kanika Bagai & Jennifer Molano (12/09) A Comparison of Two Criteria for the Diagnosis of Obstructive Sleep Apnea (abstract submitted 12/15/09)
  81. Dr.Kanika Bagai & Alyson Ryan (12/09) PSG and EKG for detecting arrhythmias (abstract submitted 12/15/09)
  82. Dr Nabil J Azar (12/09) Non-diagnostic initial long-term video-EEG study, and yield of repeat studies. (abstract submitted 12/01/09)
  83. Dr Scott Boyd (3/10) Safety study of MMO surgery. (Report)
  84. Ana (Carter Lab) (1/10) Discussion on statistical tests for categorical data.
  85. Eric Armour and Dr Kevin Ess (12/09) Discussion on analysis of kiney weight in mice.
  86. Dr Nabil J Azar (11/09) Non-diagnostic initial long-term video-EEG study, and yield of repeat studies.
  87. Dr Andrea Lagrange (11/09) Discussion on nonlinear models.
  88. Dr Martin Gallagher (11/09) Consultations on multiple group KS test.
  89. Dr Kanika Bagai (7/09) Variability in Endothelial Function and Fibrinolytic balance in OSA
  90. Dr. Amir Arain (5/09) Pseudoseizure communication study.
  91. Dr. Amir Arain (5/09) Epilepsy Monitoring satisfaction survey.
  92. Dr Fanglin Zhang (Sriram Lab) (5/09) Pathway analysis of microarray datasets. (Report)
  93. Dr David Charles and Elyne Kahn (3/09) DEEP BRAIN STIMULATION: ITS EFFECT ON RATE OF INCREASE OF ANTIPARKINSONIAN MEDICATION.
  94. Dr Amanda Peltier (4/09) Prevention of peripheral neuropathy by treating metabolic syndromes in HIV patients.
  95. Dr Fanglin Zhang,Subramaniam Sriram (2/09) Discussion on a microarray study with repeated measures.
  96. Drs Lisa Hermann, Kirshner Howard (12/08) External Ventricular Drain in stroke treatment.
  97. Dr Christopher Nolte (11/08) Discussions on analysis of CPAP (continuous positive airway pressure) machine use.
  98. Dr Kevin Haas (11/08) Dose response study for Mice with Angelman syndrome. (Report)
  99. Dr Christopher Lee (11/08) Brief consultation on repeated measures analysis.
  100. Dr Vishal Jani (10/08) MESA study discussions.
  101. Dr Mostafa Hammoudi (9/08) Discussion on an EEG study.
  102. Dr Chris Kao (9/08) Discussion of a paper.
  103. Dr Subramaniam Sriram (9/08) Efficacy of DFP to reduce Fe in dentate nuclei: MRI metrics of efficacy.
  104. Dr Arain Amir (8/08 - 12/08) Analysis of Hospital Discharge Database
  105. Dr Liya Beyderman (7/08) Analysis of statistics related to consultations at Vanderbilt Adult Neurology clinic.
  106. Dr Bassel Abou-khalil (7/08) The association of temporal tip epilepsy and hypermotor seizures.
  107. Dr Christopher Michael (6/08) Literacy/numeracy testing between adherent and non-adherent CPAP patients.
  108. Dr.Pradumna Singh, Dr. Nandakumar Bangalore (5/08) Does intravenous levetiracetam have a role in the management of acute repetitive seizures?
  109. Dr. Nabil Azar, Dr.Bassel Abou-Khalil (5/08) Seizure interval prolongation (SIP) after brief AED withdrawal- experience with new AEDs.
  110. Dr.Amir Arain (5/08) DIAGNOSTIC YIELD OF REGULAR EEG VERSUS 2 HRS LONG TERM OUTPATIENT VIDEO EEG MONITORING.
  111. Dr. Amir Arain (5/08) Racial disparity in Patients Admitted to Hospitals in Tennessee for Epilepsy and Seizures .
  112. Dr. Amir Arain (5/08) Psychopathology and Family Dynamics in Patients with Psychogenic Non-Epileptic Spells (PNES).
  113. Dr Kevin Ess (5/08) Survival Analysis of Rapamycin treated CKO mice.
  114. Dr Siddharama Pawate (4/08) Mycophenolate Mofetil in the Treatment of Multiple Sclerosis. Poster.
  115. Neil Manus (11/07-2/08) Retrospective CD project.
  116. Dr. Nandakumar Bangalore Vittal (12/07) Sample size calculations for a research proposal.
  117. Dr. Martin J. Gallagher (12/07) Stats question.
  118. Drs Gregory Barnes and John Flatt (10/07) Sample size calculations for a clincal trial.
  119. Dr Suzanne Goldman (10/07) Stats questions and data management for Williams Syndrome study.
  120. Dr Siddharama Pawate (10/07) Mycophenolate Mofetil in the treatment of Multiple Sclerosis. (Abstract for conference)
  121. Dr Andrea Lagrange (6/07)The effect of RNA editing to modify GABA-A receptor properties.
  122. Dr David Charles (5/07)The therapeutic use of botulinum toxin type A in treating neck and upper back pain of muscular origin: a pilot study.
  123. Dr. Mengesha, Theodros (6/07) Quantitative Analysis of Visual Field Defects after Selective Amygdalohippocampectomy and Standard Temporal Lobectomy. Data analysis.
  124. Dr Alwan, Ahmad (5/07) Clinical and electrophysiologic characterization of seizures occurring in waking versus sleep. Data collection and analysis.
  125. Dr David Charles (2/07 ) Safety and Tolerability of Neurostimulation in Early State Parkinsonís Disease. Data Monitoring Committee report.
  126. Dr Pradumna P Singh et al. (11/06 -) The Characteristics of Patients Visiting Emergency Room Repeatedly for Seizures.
  127. Dr. Amanda C. Peltier (9/06)Discussion on a retrospective case-control study.
  128. Dr Greg Barnes (9/06)Risk factors for developing post-neonatal epilepsy. Suggestions on revision of manuscript.
  129. Dr. Tom Davis (7/06) Discussion on crossover study.
  130. Dr Ajay Shukla (7/06) Significance of median motor nerve latency and amplitude in deciding the surgical treatment of CTS. Discussion on manuscipt writing.
  131. Dr. BethAnn McLaughlin (7/06) Evaluating the changes in mitochondrial membrane potential induced by isoprostanes under normal and hypoxic conditions.Calculation and estimation of statistical parameters.
  132. Dr Kimberly Hutchison (5/06) Neural correlates of adaptation to sleep deprivation in obstructive sleep apnea - A Pilot Study.
  133. Courtney Schadt (3/06)Reduction of medical costs after DBS surgury.(Abstract)
  134. Drs Fenna Phibbs and John Fang (3/06) Manganese, Movement Disorders, and Welding. Sample size calculation.
  135. Dr Andre Lagrange (3/06) Database questions.
  136. Dr Sriram, Subramaniam (2/06) Discussion of paper on Meta-Analysis.
  137. Dr Michael K. Cooper (2/06) Analysis of Hedgehog pathway activity in brain tumors. Assistance with manuscript preparation.
  138. Drs Annette Chihorek, Beth Malow (2/06) Obstructive sleep apnea in older adults with epilepsy.
  139. Dr David Charles (1/06) Prevalence of spasticity in adults with mental retardation. Sample size calculation.
  140. Dr Fenna Phibbs (1/06)Analysis of a multivariate crossover study.

Presentations

  1. Design of clinical studies - case-control study, Oct 12 2006.
  2. Data management and analysis for successful clinical research, May 18, 2010 slides, handout
  3. Working with biostatisticians lecture for clinical research series, Sept 17, 2012
Topic revision: r103 - 05 Jan 2015, LilyWang
 

This site is powered by FoswikiCopyright © 2013-2017 by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Vanderbilt Biostatistics Wiki? Send feedback